• 

  COVID-19 May Hasten Alzheimer’s Symptoms
• 

  Pollution and Dementia: Scientists Link Air Quality and Brain Health
• 

  The Link Between Energy Deficiency in the Brain and Alzheimer’s
• 

  Meet Lilly’s Investigational Alzheimer’s Drug Donanemab: A Q&A With Dr. David Weidman
• 

  Neuroscientist Daniela Kaufer: Aging, Disease, and the Blood-Brain Barrier
• 

  Audiologist Danielle Powell: Navigating Hearing Loss in Aging and Dementia
• 

  Some Hospitals Refuse to Offer Alzheimer’s Drug Aduhelm
• 

  Amyloid Hypothesis Twist: Restoring ‘Good’ Beta-Amyloid to Treat Alzheimer’s
• 

  FDA Limits the Use of Aduhelm After Criticisms of Broad Approval
• 

  A Virtual Microscope for Alzheimer’s Earns FDA ‘Breakthrough’ Designation
• 

  A Reason To Reach Out: The Therapeutic Power of a Phone Call
• 

  The Questions Doctors Are Getting About Aduhelm Right Now—And Their Answers
• 

  Neuroscientist Lisa Genova: How to Spot — and Prevent — Memory Loss
• 

  ‘Cautiously Optimistic:’ Cancer Drug Sargramostim May Improve Memory in Alzheimer’s
• 

  A Retired Neurologist’s on His Own Alzheimer’s Journey

Previous678Next